Results 11 to 20 of about 2,266,477 (255)
Drug Design and Development for Rare Hematologic Diseases. [PDF]
Pharmaceuticals (Basel), 2023 The last decade has seen an exponential increase in therapeutic options for rare hematologic ...
Fattizzo B, Capecchi M, Motta I.
europepmc +2 more sources
COVID-19 in Patients with Hematologic Diseases. [PDF]
Biomedicines, 2022 first_pagesettingsOrder Article Reprints Open AccessReview COVID-19 in Patients with Hematologic Diseases by Ilaria Carola Casetti 1ORCID,Oscar Borsani 1,2ORCID andElisa Rumi 1,2,*ORCID 1 Department of Molecular Medicine, University of Pavia, 27100 ...
Casetti IC, Borsani O, Rumi E.
europepmc +3 more sources
Invasive Fusariosis in Patients with Hematologic Diseases. [PDF]
J Fungi (Basel), 2021 Fusarium species are filamentous fungi widely encountered in nature, and may cause invasive disease in patients with hematologic conditions. Patients at higher risk are those with acute leukemia receiving induction remission chemotherapy or allogeneic ...
Nucci M +4 more
europepmc +2 more sources
Outcomes of splenectomy for hematologic diseases-a single center experience
, 2021 © 2021, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.Splenectomy is a standard, effective and approved approach to the treatment of patients with failed medical treatment who develop recurrent, refractory or chronic diseases.
Kotan, Mehmet Çetin +4 more
core +1 more source
Mucormycosis in Hematologic Malignancies: Clinical Follow-Up and Treatment Results [PDF]
, 2021 Introduction:Mucormycosis is an aggressive-progressive invasive fungal infection caused by mold fungi in the division of mucorales of the zygomycetes class with high mortality, and is the most common fungal infection in patients with hematologic ...
Mehmet Hilmi Doğu +3 more
core +1 more source
Hematologic manifestations of theumatic diseases [PDF]
, 2018 Rheumatic diseases are, by their very nature, multisystemic entities with vast array of possible hematologic manifestations. The mechanisms of different hematologic manifestations tend to be complex and vary from patient to patient.
Wanda Dobryniewska +13 more
core +1 more source
ANORECTAL COMPLICATIONS DURING NEUTROPENIC PERIOD IN PATIENTS WITH HEMATOLOGIC DISEASES [PDF]
, 2016 Background: Neutropenic patients are susceptible to any anorectal disease, and symptomatic anorectal disease afflicts 2-32% of oncology patients. Perianal infections are the most feared complication, considering the lack of natural defense against ...
Kozanoglu, Ilknur +10 more
core +1 more source
Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond
, 2022 : Complement is an elaborate system of innate immunity. Genetic variants and autoantibodies leading to excessive complement activation are implicated in a variety of human diseases. Among them, the hematologic disease paroxysmal nocturnal hemoglobinuria (
Gavriilaki, Eleni +2 more
core +1 more source
BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES [PDF]
, 2015 Splenectomy, while often necessary in otherwise healthy patients after major trauma, find its primary indication for patients with an underlying malignant or nonmalignant hematologic diseases.
Eligio Pizzigallo, Giuseppe Leone
core +1 more source
Hyponatremia in Patients with Hematologic Diseases
, 2020 Hyponatremia is the most common electrolyte disorder in clinical practice and is associated with increased morbidity and mortality. It is frequently encountered in hematologic patients with either benign or malignant diseases.
Matilda Florentin +3 more
core +1 more source